GE HealthCare (Nasdaq: GEHC) aims to bolster its radiopharmaceutical supply chain with a $945 million cash deal to buy Sofie Biosciences and its U.S. network of manufacturing sites. The goal is to obtain last-mile logistics for radioactive imaging agents that have a short half-life and need to be produced as close to patients as possible.…
